Dysfunctions, molecular mechanisms, and therapeutic strategies of pancreatic β-cells in diabetes

被引:13
|
作者
Prasad, Murali Krishna [1 ]
Mohandas, Sundhar [1 ]
Ramkumar, Kunka Mohanram [1 ]
机构
[1] SRM Inst Sci & Technol, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India
关键词
Diabetes mellitus; Apoptosis; Cell death; Polyphenols; Beta cells; Natural products; ENDOPLASMIC-RETICULUM STRESS; NLRP3 INFLAMMASOME ACTIVATION; UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; METABOLIC STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; HIGH-FAT; T-CELLS; DEATH;
D O I
10.1007/s10495-023-01854-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic beta-cell death has been established as a critical mediator in the progression of type 1 and type 2 diabetes mellitus. Beta-cell death is associated with exacerbating hyperglycemia and insulin resistance and paves the way for the progression of DM and its complications. Apoptosis has been considered the primary mechanism of beta-cell death in diabetes. However, recent pieces of evidence have implicated the substantial involvement of several other novel modes of cell death, including autophagy, pyroptosis, necroptosis, and ferroptosis. These distinct mechanisms are characterized by their unique biochemical features and often precipitate damage through the induction of cellular stressors, including endoplasmic reticulum stress, oxidative stress, and inflammation. Experimental studies were identified from PubMed literature on different modes of beta cell death during the onset of diabetes mellitus. This review summarizes current knowledge on the crucial pathways implicated in pancreatic beta cell death. The article also focuses on applying natural compounds as potential treatment strategies in inhibiting these cell death pathways.
引用
下载
收藏
页码:958 / 976
页数:19
相关论文
共 50 条
  • [31] Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
    Bernardo, Antonietta
    Visentin, Sergio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [32] Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes
    Liao, Helen Ziqing
    Liang, Yanting
    Wang, Ye
    Liang, Chun
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (11) : 1392 - 1399
  • [33] Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
    Zhao, Lu
    Hu, Haoran
    Zhang, Lin
    Liu, Zheting
    Huang, Yunchao
    Liu, Qian
    Jin, Liang
    Zhu, Meifei
    Zhang, Ling
    MEDCOMM, 2024, 5 (04):
  • [34] An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory
    Yang, Tongyue
    Qi, Feng
    Guo, Feng
    Shao, Mingwei
    Song, Yi
    Ren, Gaofei
    Linlin, Zhao
    Qin, Guijun
    Zhao, Yanyan
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [36] Mechanisms-based therapeutic strategies in type 2 diabetes
    Paneni, Francesco
    Costantino, Sarah
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2015, 5 (05) : 340 - 342
  • [37] Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
    Yakovenko, Anastasiya
    Cameron, Miles
    Trevino, Jose Gilberto
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 10 (09): : 95 - 106
  • [38] Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors
    Gilbert, Judith A.
    Adhikari, Laura J.
    Lloyd, Ricardo V.
    Halfdanarson, Thorvardur R.
    Muders, Michael H.
    Ames, Matthew M.
    PANCREAS, 2013, 42 (03) : 411 - 421
  • [39] Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies
    Huang, Huizhen
    Lu, Wanyi
    Zhang, Xiuli
    Pan, Jiachun
    Cao, Feng
    Wen, Li
    CELLULAR ONCOLOGY, 2024, 47 (02) : 383 - 396
  • [40] Novel Strategies to Protect and Visualize Pancreatic β Cells in Diabetes
    Gurzov, Esteban N.
    Ke, Pu Chun
    Ahlgren, Ulf
    Ribeiro, Rita S. Garcia
    Gotthardt, Martin
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (12): : 905 - 917